Neuren Pharmaceuticals | Des Atouts



Assets Changement Date
Alaunos Therapeutics USD 3.55M 1.13M 2024-09
Avita Medical AUD 79.71M 8.12M 2024-12
Clinuvel Pharmaceuticals AUD 231.12M 19.44M 2024-06
Dianthus Therapeutics USD 354.25M 14.71M 2024-09
Ecofibre AUD 71.25M 1.95M 2024-06
Genetic Signatures AUD 67.29M 22.83M 2024-06
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
Medical Developments International AUD 59.16M 31.9M 2024-06
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Opthea USD 188.79M 22.29M 2024-06
Organon & Co USD 12.75B 598M 2024-09
Paradigm Biopharmaceuticals AUD 27.39M 17.65M 2024-06
PYC Therapeutics AUD 91.24M 51.48M 2024-06
Starpharma Holdings AUD 36.81M 7.12M 2024-06
Tectonic Therapeutic USD 168.72M 25.19M 2024-09
Telix Pharmaceuticals AUD 1.52B 770.47M 2024-12
Viatris USD 41.5B 3.25B 2024-12
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12



Neuren Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.